Weight Loss

First, the part that matters most: retatrutide is an investigational drug that is not FDA approved, and there is no approved dosing for it….

No. As of June 2026, retatrutide is not FDA approved. It remains an investigational drug in Phase 3 clinical trials, which means it cannot…

The most common retatrutide side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. They tend to be mild to moderate, show up mostly during…

Retatrutide is an investigational weight loss medication that acts on three hormone receptors at the same time: GLP-1, GIP, and glucagon. Developed by Eli…

Introduction The honest weight regain statistics are rough: across decades of diet research, most people regain most of their lost weight within 3 to…

Introduction The fastest way to spot a fake GLP-1 seller in 2026 is simple: if they sell you a prescription drug without any medical…

Introduction The best wedding-season weight loss programs work backward from a date on a calendar, which makes them different from every other program on…

Introduction While losing 20 percent of your body weight on a GLP-1, the benchmark that matters is this: your key lifts should finish within…

State insurance mandates for obesity drugs decide, more than any other single factor, whether a GLP-1 costs you $25 or $500 a month.